248 related articles for article (PubMed ID: 22378040)
1. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.
Worzfeld T; Swiercz JM; Looso M; Straub BK; Sivaraj KK; Offermanns S
J Clin Invest; 2012 Apr; 122(4):1296-305. PubMed ID: 22378040
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
4. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
Sun T; Krishnan R; Swiercz JM
J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
[TBL] [Abstract][Full Text] [Related]
5. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.
Swiercz JM; Kuner R; Offermanns S
J Cell Biol; 2004 Jun; 165(6):869-80. PubMed ID: 15210733
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
[TBL] [Abstract][Full Text] [Related]
7. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
Grothey A; Hashizume R; Ji H; Tubb BE; Patrick CW; Yu D; Mooney EE; McCrea PD
Oncogene; 2000 Oct; 19(42):4864-75. PubMed ID: 11039904
[TBL] [Abstract][Full Text] [Related]
8. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
9. Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion.
Ye S; Hao X; Zhou T; Wu M; Wei J; Wang Y; Zhou L; Jiang X; Ji L; Chen Y; You L; Zhang Y; Xu G; Zhou J; Ma D; Wang S
BMC Cancer; 2010 Nov; 10():611. PubMed ID: 21059203
[TBL] [Abstract][Full Text] [Related]
10. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
Rody A; Holtrich U; Gaetje R; Gehrmann M; Engels K; von Minckwitz G; Loibl S; Diallo-Danebrock R; Ruckhäberle E; Metzler D; Ahr A; Solbach C; Karn T; Kaufmann M
Clin Cancer Res; 2007 Feb; 13(4):1115-22. PubMed ID: 17317819
[TBL] [Abstract][Full Text] [Related]
11. Plexin-B1 mutations in prostate cancer.
Wong OG; Nitkunan T; Oinuma I; Zhou C; Blanc V; Brown RS; Bott SR; Nariculam J; Box G; Munson P; Constantinou J; Feneley MR; Klocker H; Eccles SA; Negishi M; Freeman A; Masters JR; Williamson M
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19040-5. PubMed ID: 18024597
[TBL] [Abstract][Full Text] [Related]
12. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
[TBL] [Abstract][Full Text] [Related]
13. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
14. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
[TBL] [Abstract][Full Text] [Related]
15. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.
Basile JR; Gavard J; Gutkind JS
J Biol Chem; 2007 Nov; 282(48):34888-95. PubMed ID: 17855350
[TBL] [Abstract][Full Text] [Related]
16. Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas.
Ebbesen SH; Scaltriti M; Bialucha CU; Morse N; Kastenhuber ER; Wen HY; Dow LE; Baselga J; Lowe SW
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3030-5. PubMed ID: 26929372
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D signaling requires the recruitment of phospholipase C gamma into the plexin-B1 receptor complex.
Swiercz JM; Worzfeld T; Offermanns S
Mol Cell Biol; 2009 Dec; 29(23):6321-34. PubMed ID: 19805522
[TBL] [Abstract][Full Text] [Related]
18. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα.
Xiao Y; Lin VY; Ke S; Lin GE; Lin FT; Lin WC
Mol Cell Biol; 2014 Jul; 34(14):2635-49. PubMed ID: 24820414
[TBL] [Abstract][Full Text] [Related]
20. Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.
Stevens L; McClelland L; Fricke A; Williamson M; Kuo I; Scott G
J Invest Dermatol; 2010 Jun; 130(6):1636-45. PubMed ID: 20164843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
